VAUGHAN, Ontario—Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company, has announced European commercial availability of the preloaded enVista Envy full range of vision intraocular lens (IOL), which offers excellent dysphotopsia tolerance on the widely used enVista IOL platform.
Quick Take
Bausch + Lomb has launched the preloaded enVista Envy full range of vision intraocular lens (IOL) in Europe, expanding its premium lens portfolio. This new offering utilizes the established enVista platform to provide a continuous range of vision while prioritizing high tolerance for dysphotopsia.
Why It Matters
As patient expectations for spectacle independence after cataract surgery rise, the industry is shifting toward 'full range of vision' lenses that minimize the visual disturbances common with older multifocal designs. This launch brings a preloaded option to the European market, combining the stability of the enVista platform with a delivery system designed to enhance surgical efficiency. For practices, this represents a new tool for addressing the common clinical trade-off between achieving a broad visual range and maintaining night-vision quality.
Key Details
Practice Implications
European cataract surgeons can now offer a new premium IOL option that aims to balance extended visual range with a lower side-effect profile. The preloaded format may help improve operating room throughput and reduce the manual handling required for lens preparation.
Who's Affected
AI-generated summary — always read the original source for full context
No comments yet. Be the first to share your thoughts.
